(0.05%) 5 251.23 points
(0.02%) 39 769 points
(-0.16%) 16 374 points
(2.14%) $83.09
(2.10%) $1.754
(1.29%) $2 241.30
(0.73%) $24.93
(1.30%) $921.55
(0.35%) $0.927
(0.79%) $10.85
(0.14%) $0.792
(0.13%) $92.56
Live Chart Being Loaded With Signals
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 7.09M |
Average Volume | 4.88M |
Market Cap | 61.18B |
EPS | HKD0 ( 2024-03-21 ) |
Next earnings date | ( HKD0 ) 2024-04-25 |
Last Dividend | HKD0.901 ( 2023-06-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.32 |
ATR14 | HKD0.0240 (0.12%) |
Volume Correlation
SINOPHARM GROUP CO LTD Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
SINOPHARM GROUP CO LTD Correlation - Currency/Commodity
SINOPHARM GROUP CO LTD Financials
Annual | 2022 |
Revenue: | HKD552.15B |
Gross Profit: | HKD47.43B (8.59 %) |
EPS: | HKD4.60 |
Q3 | 2023 |
Revenue: | HKD144.97B |
Gross Profit: | HKD144.97B (100.00 %) |
EPS: | HKD0 |
Q2 | 2023 |
Revenue: | HKD300.95B |
Gross Profit: | HKD23.27B (7.73 %) |
EPS: | HKD1.320 |
Q4 | 2022 |
Revenue: | HKD145.77B |
Gross Profit: | HKD-119.13B (-81.73 %) |
EPS: | HKD0.850 |
Financial Reports:
No articles found.
SINOPHARM GROUP CO LTD Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.901 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0101 | 2010-04-29 |
Last Dividend | HKD0.901 | 2023-06-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD6.94 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.91 | -- |
Div. Sustainability Score | 9.86 | |
Div.Growth Potential Score | 5.26 | |
Div. Directional Score | 7.56 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8095.HK | Ex Dividend Junior | 2023-10-17 | Sporadic | 0 | 0.00% | |
2030.HK | Ex Dividend Junior | 2023-08-17 | Annually | 0 | 0.00% | |
1110.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% | |
0189.HK | Ex Dividend Knight | 2023-06-14 | Annually | 0 | 0.00% | |
3709.HK | Ex Dividend Knight | 2023-06-14 | Annually | 0 | 0.00% | |
1681.HK | Ex Dividend Knight | 2023-06-08 | Semi-Annually | 0 | 0.00% | |
0728.HK | Ex Dividend Knight | 2023-08-23 | Annually | 0 | 0.00% | |
2219.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
1258.HK | Ex Dividend Knight | 2023-06-30 | Annually | 0 | 0.00% | |
0322.HK | Ex Dividend Knight | 2023-06-07 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0148 | 1.500 | 9.70 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0262 | 1.200 | 9.13 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.159 | 1.500 | 9.35 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.214 | -1.000 | 7.86 | -7.86 | [0 - 1] |
currentRatioTTM | 1.323 | 0.800 | 8.39 | 6.71 | [1 - 3] |
quickRatioTTM | 0.981 | 0.800 | 8.94 | 7.15 | [0.8 - 2.5] |
cashRatioTTM | 0.122 | 1.500 | -0.432 | -0.648 | [0.2 - 2] |
debtRatioTTM | 0.227 | -1.500 | 6.22 | -9.32 | [0 - 0.6] |
interestCoverageTTM | 11.93 | 1.000 | 6.69 | 6.69 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.01 | 2.00 | 8.33 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.14 | 2.00 | 7.93 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.362 | -1.500 | 4.55 | -6.83 | [0 - 2.5] |
grossProfitMarginTTM | 0.263 | 1.000 | 8.94 | 8.94 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0337 | 1.000 | -1.325 | -1.325 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.164 | 1.000 | -0.198 | -0.198 | [0.2 - 2] |
assetTurnoverTTM | 1.763 | 0.800 | 1.577 | 1.261 | [0.5 - 2] |
Total Score | 9.86 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 5.33 | 1.000 | 9.56 | 0 | [1 - 100] |
returnOnEquityTTM | 0.159 | 2.50 | 9.58 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.14 | 2.00 | 8.62 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.82 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.01 | 2.00 | 8.33 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.214 | 1.500 | 7.86 | -7.86 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0212 | 1.000 | -1.971 | 0 | [0.1 - 0.5] |
Total Score | 5.26 |
SINOPHARM GROUP CO LTD
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators